&Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.56M | Sell |
120,079
-23,686
| -16% | -$1.1M | 0.04% | 348 |
|
|
2025
Q1 | $8.63M | Buy |
143,765
+10,722
| +8% | +$643K | 0.09% | 211 |
|
|
2024
Q4 | $7.49M | Buy |
133,043
+40,301
| +43% | +$2.27M | 0.09% | 220 |
|
|
2024
Q3 | $4.82M | Buy |
92,742
+41,662
| +82% | +$2.16M | 0.09% | 208 |
|
|
2024
Q2 | $2.12M | Buy |
51,080
+33,469
| +190% | +$1.39M | 0.09% | 206 |
|
|
2024
Q1 | $955K | Buy |
17,611
+7,616
| +76% | +$413K | 0.13% | 159 |
|
|
2023
Q4 | $513K | Buy |
9,995
+2,652
| +36% | +$136K | 0.13% | 153 |
|
|
2023
Q3 | $426K | Sell |
7,343
-440
| -6% | -$25.5K | 0.2% | 95 |
|
|
2023
Q2 | $498K | Sell |
7,783
-550
| -7% | -$35.2K | 0.22% | 86 |
|
|
2023
Q1 | $578K | Sell |
8,333
-260
| -3% | -$18K | 0.28% | 68 |
|
|
2022
Q4 | $618K | Sell |
8,593
-40
| -0.5% | -$2.88K | 0.31% | 66 |
|
|
2022
Q3 | $614K | Buy |
8,633
+344
| +4% | +$24.5K | 0.36% | 67 |
|
|
2022
Q2 | $631K | Buy |
8,289
+159
| +2% | +$12.1K | 0.36% | 66 |
|
|
2022
Q1 | $594K | Buy |
8,130
+3,240
| +66% | +$237K | 0.33% | 70 |
|
|
2021
Q4 | $305K | Sell |
4,890
-100
| -2% | -$6.24K | 0.18% | 126 |
|
|
2021
Q3 | $295K | Buy |
4,990
+110
| +2% | +$6.5K | 0.19% | 124 |
|
|
2021
Q2 | $326K | Buy |
4,880
+50
| +1% | +$3.34K | 0.21% | 109 |
|
|
2021
Q1 | $305K | Buy |
4,830
+500
| +12% | +$31.6K | 0.22% | 106 |
|
|
2020
Q4 | $293K | Buy |
4,330
+900
| +26% | +$60.9K | 0.25% | 98 |
|
|
2020
Q3 | $243K | Sell |
3,430
-1,500
| -30% | -$106K | 0.25% | 97 |
|
|
2020
Q2 | $290K | Hold |
4,930
| – | – | 0.35% | 75 |
|
|
2020
Q1 | $275K | Sell |
4,930
-500
| -9% | -$27.9K | 0.43% | 75 |
|
|
2019
Q4 | $349K | Buy |
+5,430
| New | +$349K | 0.42% | 83 |
|